Alzheimer's Disease, Apolipoprotein E4, and Gender
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To the Editor. —Researchers at Duke University have shown that apolipoproteinE4(apo E) gene dosage correlates with increased risk of Alzheimer's disease (AD).1Their study included members of 42 families with late-onset AD (age at onset, >60 years) with known apo E genotype and used Kaplan-Meier survival analysis to estimate the age-of-onset curves for subjects with zero, one, and twoE4alleles. The resulting curves revealed a significant dosage effect, where each additionalE4allele shifted the onset to an earlier age. We have performed a similar study, which included members of 52 families with late-onset AD (age at onset, >60 years) with known apo E genotype and used Kaplan-Meier survival analysis to estimate the age-of-onset curves for subjects with zero, one, and twoE4alleles. Our study included 252 individuals with known age and apo E genotype; 38 were younger than 60 years,
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“risk allele variants at the APOE locus have a stronger effect in females than in males [60].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [60]
In the citing paper
“the APOE ε4 variant, which is the most common genetic risk factor for Alzheimer’s Disease, has a significantly stronger effect on disease risk in women than in men11,12”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [11]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Cited by
Sex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891
“Shortly after the initial linkage studies, a prominent interaction between APOE and sex was reported.(14) The first large meta-analysis of APOE4 studies confirmed the interaction and found that the effect was most prominent among subjects with 1 copy of the APOE4 allele and 1 copy of the risk-neutral APOE3 allele.”
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S. P., Redolfi, A., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2188 · Cited by 674
Age, APOE and sex: triad of risk of Alzheimer’s disease.
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570
“, and Schellenberg, G.D. (2005). APOE and other loci affect age-at-onset in Alzheimer’s disease families with PS2mutation.”
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493
Metadata
- Authors
- Payami, H.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Payami, Haydeh
- ORCID
- Payami, Haydeh
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1994-05-04
- Volume
- 271
- Issue
- 17
- Pages
- 1316
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2044699328
- Cited by
- 190
- References
- 1
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 27 · 2023: 16 · 2022: 8 · 2021: 13 · 2020: 10 · 2019: 6 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 1
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, APOE ε4, late-onset Alzheimer's disease, gene dosage effect, age of onset, family studies, sex differences, genetic risk
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Female, Humans, Male, Sex Factors, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer's Disease, Apolipoprotein E4, and Gender. https://app.cochat.ai/papers/10.1001/jama.1994.03510410028015
- The paper
- Payami, H. (1994). Alzheimer's Disease, Apolipoprotein E4, and Gender. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1994.03510410028015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.